Smith & Nephew PLC
SNN33.420USD
+0.540+1.64%
終値 11/25, 16:00（ET）15分遅れの株価
14.64B時価総額
--直近12ヶ月PER
詳細情報 Smith & Nephew PLC 企業名
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Smith & Nephew PLCの企業情報
企業コードSNN
会社名Smith & Nephew PLC
上場日Aug 13, 1951
最高経営責任者「CEO」Mr. Deepak S. Nath
従業員数17349
証券種類Equity Future
決算期末Aug 13
本社所在地Building 5
都市WATFORD
証券取引所Johannesburg Stock Exchange
国United Kingdom
郵便番号WD18 8YE
電話番号4401923477100
ウェブサイトhttps://www.smith-nephew.com/
企業コードSNN
上場日Aug 13, 1951
最高経営責任者「CEO」Mr. Deepak S. Nath
Smith & Nephew PLCの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer
18.46K
--
Mr. Marc E. Owen
Mr. Marc E. Owen
Non-Executive Independent Director
Non-Executive Independent Director
8.60K
+2.06%
Ms. Alison Parkes
Ms. Alison Parkes
Chief Compliance Officer
Chief Compliance Officer
3.61K
-22.82%
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.36K
+1.07%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
2.35K
+1.08%
Mr. John Ma
Mr. John Ma
Non-Executive Independent Director
Non-Executive Independent Director
1.37K
+28.58%
Mr. Mizanu Kebede
Mr. Mizanu Kebede
Chief Quality and Regulatory Affairs Officer
Chief Quality and Regulatory Affairs Officer
1.27K
+0.95%
Mr. Scott Schaffner
Mr. Scott Schaffner
President - Sports Medicine
President - Sports Medicine
1.14K
+2.62%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer
18.46K
--
Mr. Marc E. Owen
Mr. Marc E. Owen
Non-Executive Independent Director
Non-Executive Independent Director
8.60K
+2.06%
Ms. Alison Parkes
Ms. Alison Parkes
Chief Compliance Officer
Chief Compliance Officer
3.61K
-22.82%
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.36K
+1.07%
収益内訳
通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Sports Medicine Joint Repair
982.00M
16.90%
Knee Implants
947.00M
16.30%
Advanced Wound Care
735.00M
12.65%
Arthroscopic Enabling Technologies
632.00M
10.88%
Hip Implants
619.00M
10.65%
他の
1.90B
32.62%
地域別USD
会社名
収益
比率
United States of America
3.12B
53.75%
Other Established Markets
1.27B
21.88%
Emerging &internatiuonal market
980.00M
16.87%
United Kingdom
226.00M
3.89%
China
210.00M
3.61%
事業別
地域別
事業別USD
会社名
収益
比率
Sports Medicine Joint Repair
982.00M
16.90%
Knee Implants
947.00M
16.30%
Advanced Wound Care
735.00M
12.65%
Arthroscopic Enabling Technologies
632.00M
10.88%
Hip Implants
619.00M
10.65%
他の
1.90B
32.62%
株主
更新時刻: Tue, Nov 18
更新時刻: Tue, Nov 18
株主統計
種類
株主統計
株主統計
比率
BMO Capital Markets (US)
0.76%
River Road Asset Management, LLC
0.66%
Scharf Investments, LLC
0.48%
Brandes Investment Partners, L.P.
0.29%
Optiver Holding B.V.
0.26%
他の
97.55%
株主統計
株主統計
比率
BMO Capital Markets (US)
0.76%
River Road Asset Management, LLC
0.66%
Scharf Investments, LLC
0.48%
Brandes Investment Partners, L.P.
0.29%
Optiver Holding B.V.
0.26%
他の
97.55%
種類
株主統計
比率
Investment Advisor
3.65%
Research Firm
2.01%
Investment Advisor/Hedge Fund
1.51%
Hedge Fund
0.27%
Family Office
0.17%
Family Office
0.17%
Pension Fund
0.15%
Family Office
0.12%
Individual Investor
0.01%
他の
91.94%
機関投資家保有株
更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
458
32.77M
7.72%
-12.10M
2025Q2
468
34.86M
7.96%
-12.17M
2025Q1
470
32.31M
7.38%
-15.13M
2024Q4
454
34.98M
8.00%
-9.87M
2024Q3
442
33.73M
7.72%
-17.08M
2024Q2
451
37.69M
8.62%
-9.14M
2024Q1
460
34.95M
7.99%
-8.57M
2023Q4
456
32.65M
7.47%
-10.09M
2023Q3
451
40.30M
9.23%
-2.29M
2023Q2
453
39.60M
9.07%
-7.09M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
BMO Capital Markets (US)
3.20M
0.75%
+2.62M
+455.42%
Jun 30, 2025
River Road Asset Management, LLC
3.18M
0.75%
+270.48K
+9.30%
Jun 30, 2025
Scharf Investments, LLC
2.08M
0.49%
+6.99K
+0.34%
Jun 30, 2025
Brandes Investment Partners, L.P.
1.60M
0.38%
+63.78K
+4.14%
Jun 30, 2025
Optiver Holding B.V.
1.15M
0.27%
+1.01M
+714.32%
Jun 30, 2025
Goldman Sachs Asset Management, L.P.
1.08M
0.25%
-18.79K
-1.72%
Jun 30, 2025
Parametric Portfolio Associates LLC
971.46K
0.23%
-1.36K
-0.14%
Jun 30, 2025
BNP Paribas Securities Corp. North America
644.52K
0.15%
+505.93K
+365.06%
Jun 30, 2025
Morgan Stanley & Co. LLC
823.55K
0.19%
+676.68K
+460.75%
Jun 30, 2025
詳細を見る
関連ETF
更新時刻: Thu, Nov 6
更新時刻: Thu, Nov 6
銘柄名
比率
Brandes International ETF
1.21%
ALPS Disruptive Technologies ETF
0.94%
ActivePassive International Equity ETF
0.21%
SP Funds S&P World (ex-US) ETF
0.1%
Avantis Responsible International Equity ETF
0.08%
Avantis International Equity ETF
0.06%
DFA Dimensional International Core Equity 2 ETF
0.04%
SPDR S&P Kensho New Economies Composite ETF
0.04%
DFA Dimensional Intl Sustainability Core 1 ETF
0%
SGI Enhanced Global Income ETF
0%
Brandes International ETF
比率1.21%
ALPS Disruptive Technologies ETF
比率0.94%
ActivePassive International Equity ETF
比率0.21%
SP Funds S&P World (ex-US) ETF
比率0.1%
Avantis Responsible International Equity ETF
比率0.08%
Avantis International Equity ETF
比率0.06%
DFA Dimensional International Core Equity 2 ETF
比率0.04%
SPDR S&P Kensho New Economies Composite ETF
比率0.04%
DFA Dimensional Intl Sustainability Core 1 ETF
比率0%
SGI Enhanced Global Income ETF
比率0%
配当金
過去5年間の配当金総支払額は
1.64B
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
Feb 26, 2025
SNN.NB Approximate interim Cash Dividend of gross USD 0.462 paid on May 28, 2025 going ex on Mar 28, 2025
Mar 28, 2025
May 28, 2025
Mar 28, 2025
Sep 24, 2024
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Nov 08, 2024 going ex on Oct 04, 2024
Oct 04, 2024
Nov 08, 2024
Oct 04, 2024
Mar 04, 2024
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 22, 2024 going ex on Apr 01, 2024
Apr 02, 2024
May 22, 2024
Apr 01, 2024
Aug 03, 2023
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Nov 01, 2023 going ex on Oct 05, 2023
Oct 06, 2023
Nov 01, 2023
Oct 05, 2023
Feb 27, 2023
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 17, 2023 going ex on Mar 30, 2023
Mar 31, 2023
May 17, 2023
Mar 30, 2023
Jul 29, 2022
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Oct 26, 2022 going ex on Sep 29, 2022
Sep 30, 2022
Oct 26, 2022
Sep 29, 2022
Mar 14, 2022
SNN.NB Interim Cash Dividend of gross USD 0.462 paid on May 11, 2022 going ex on Mar 31, 2022
Apr 01, 2022
May 11, 2022
Mar 31, 2022
Aug 12, 2021
SNN.NB Final Cash Dividend of gross USD 0.288 paid on Oct 27, 2021 going ex on Sep 30, 2021
Oct 01, 2021
Oct 27, 2021
Sep 30, 2021
Feb 19, 2021
SNN.NB Final Cash Dividend of gross USD 0.462 paid on May 12, 2021 going ex on Apr 05, 2021
Apr 06, 2021
May 12, 2021
Apr 05, 2021
Jul 29, 2020
SNN.NB Interim Cash Dividend of gross USD 0.288 paid on Oct 28, 2020 going ex on Oct 01, 2020
Oct 02, 2020
Oct 28, 2020
Oct 01, 2020
詳細を見る
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
よくある質問
Smith & Nephew PLCの上位5名の株主は誰ですか？
Smith & Nephew PLCの上位5名の株主は以下のとおりです。
BMO Capital Markets (US)は3.20M株を保有しており、これは全体の0.75%に相当します。
River Road Asset Management, LLCは3.18M株を保有しており、これは全体の0.75%に相当します。
Scharf Investments, LLCは2.08M株を保有しており、これは全体の0.49%に相当します。
Brandes Investment Partners, L.P.は1.60M株を保有しており、これは全体の0.38%に相当します。
Optiver Holding B.V.は1.15M株を保有しており、これは全体の0.27%に相当します。
BMO Capital Markets (US)は3.20M株を保有しており、これは全体の0.75%に相当します。
River Road Asset Management, LLCは3.18M株を保有しており、これは全体の0.75%に相当します。
Scharf Investments, LLCは2.08M株を保有しており、これは全体の0.49%に相当します。
Brandes Investment Partners, L.P.は1.60M株を保有しており、これは全体の0.38%に相当します。
Optiver Holding B.V.は1.15M株を保有しており、これは全体の0.27%に相当します。
Smith & Nephew PLCの株主タイプ上位3種は何ですか？
Smith & Nephew PLCの株主タイプ上位3種は、
BMO Capital Markets (US)
River Road Asset Management, LLC
Scharf Investments, LLC
BMO Capital Markets (US)
River Road Asset Management, LLC
Scharf Investments, LLC
Smith & Nephew PLC（SNN）の株式を保有している機関の数はいくつですか？
2025Q3時点で、Smith & Nephew PLCの株式を保有している機関は458社あり、保有株式の総市場価値は約32.77Mで、全体の7.72%を占めています。2025Q2と比較して、機関の持ち株は-0.24%増加しています。
Smith & Nephew PLCの最大の収益源は何ですか？
FY2024において、Sports Medicine Joint Repair部門がSmith & Nephew PLCにとって最大の収益を生み出しており、その金額は982.00Mで、全収益の16.90%を占めています。
